Epicrispr Biotechnologies vs Kanvas Biosciences

Epicrispr Biotechnologies vs Kanvas Biosciences, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Kanvas Biosciences on 51/100.

Epicrispr Biotechnologies logo
Epicrispr BiotechnologiesEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Try Epicrispr Biotechnologies
Kanvas Biosciences logo
Kanvas BiosciencesA full-stack spatial biology company.
Try Kanvas Biosciences

Where each one leads

Epicrispr Biotechnologies

  • our overall score: 62/100 against 51/100
  • domain rating: 40/100 against 24/100
  • funding raised: $90.0M against $58.0M
  • LinkedIn following: 7,025 against 3,902

Kanvas Biosciences

  • agent readiness: 53/100 against 39/100

At a glance

MeasureEpicrispr BiotechnologiesKanvas Biosciences
What it isEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).A full-stack spatial biology company.
CategoryBiotechnology, Therapeutics, Rare Diseases, EpigeneticsBiotechnology, Healthcare, Drug Discovery, Spatial Biology
Sells toBusiness modelB2BB2B
OfferingPlatformServices
Founded20202021
HeadquartersSouth San Francisco, United StatesPrinceton, USA
StatusActiveActive

Size, funding and growth

MeasureEpicrispr BiotechnologiesKanvas Biosciences
Employees5141
Total funding$90.0M$58.0M
Latest roundSeries CFunding Round
LinkedIn followers7,0253,902

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEpicrispr BiotechnologiesKanvas Biosciences
StartupHub scoreOur 0-100 rating62/10051/100
Traction57/10055/100
Team40/10010/100
Search visibility20/10036/100
Quality78/10062/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)D (53/100)
Domain ratingLink authority, 0-10040/10024/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEpicrispr BiotechnologiesKanvas Biosciences
CDNCloudflareCloudflare
CMSWordPressNot detected
FrameworksJquery, Tailwind CSS, BootstrapTailwind CSS
AnalyticsGoogle Analytics 4Google Analytics 4

Epicrispr Biotechnologies vs Kanvas Biosciences: common questions

Which is better, Epicrispr Biotechnologies or Kanvas Biosciences?

On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.

How do Epicrispr Biotechnologies and Kanvas Biosciences compare on the numbers?

Epicrispr Biotechnologies leads on our overall score (62/100 against 51/100), domain rating (40/100 against 24/100), funding raised ($90.0M against $58.0M), LinkedIn following (7,025 against 3,902). Kanvas Biosciences leads on agent readiness (53/100 against 39/100).

Read the full Epicrispr Biotechnologies review and pricing or the Kanvas Biosciences review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.